Literature DB >> 10797493

Vascular endothelial growth factor-A expression in the rat ventral prostate gland and the early effects of castration.

M Burchardt1, T Burchardt, M W Chen, O R Hayek, C Knight, A Shabsigh, A de La Taille, R Buttyan.   

Abstract

BACKGROUND: Blood flow to the rat ventral prostate gland is drastically reduced during the very early period after castration, and this reduction coincides with the appearance of striking degenerative changes within the prostatic vascular system. These early effects on the prostate vascular system are likely to be important for the subsequent regression of the ventral prostate that occurs in response to castration. Since the endothelial cells of the ventral prostate do not express androgen receptor protein (AR), we proposed that these early effects might be indirectly mediated by changes in the local expression of vascular regulatory factors. In order to evaluate whether vascular endothelial growth factor-A (VEGF-A) might be among the primary mediators of these effects, we measured expression of VEGF-A mRNA and protein in the rat ventral prostate gland prior to and within the first 3 days after castration.
METHODS: Ventral prostate tissues were obtained from control (unoperated) rats, sham-operated rats, or rats at sequential daily intervals (1-3 days) after castration. A quantitative RNase protection assay and a comparative RT-PCR assay were used to evaluate the extent to which the expression of VEGF-A mRNA in the ventral prostate was affected by castration. In situ immunohistochemistry, using an anti-VEGF-A antibody, was performed to localize VEGF-A protein in the various cells of the tissue. Western blot analysis and a quantitative ELISA assay using anti-VEGF-A antibodies were performed to determine how VEGF-A protein expression in the rat ventral prostate was affected by castration.
RESULTS: Results of VEGF-A mRNA analysis in the rat ventral prostate gland during the first 3 days after castration showed a biphasic change characterized by a transient reduction of VEGF-A mRNA expression (by approximately 50%) on the second day after castration that was restored to higher than control levels by the third day after castration. Immunohistochemical analysis for VEGF-A in control and castrated ventral prostates showed that the prostatic epithelial and smooth muscle cells were the major source of VEGF-A expression in this tissue. Quantitative analysis of VEGF-A protein expression by Western blot and ELISA methods confirmed a biphasic change in the expression of the polypeptide that correlated well with the results of the mRNA analyses.
CONCLUSIONS: VEGF-A expression in the ventral prostate gland of the Sprague-Dawley rat is downregulated on the second day after castration but returns to control levels by the third day after castration. Since critical changes in the ventral prostate vascular system are already evident by 1 day after castration, we believe that these findings indicate that VEGF-A is not likely to be the critical or sole mediator of the early effects of castration on the vascular system of the rat ventral prostate gland. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10797493     DOI: 10.1002/(sici)1097-0045(20000515)43:3<184::aid-pros4>3.0.co;2-6

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  8 in total

1.  Vascular endothelial growth factor and angiopoietin are required for prostate regeneration.

Authors:  Gui-Min Wang; Bruce Kovalenko; Yili Huang; David Moscatelli
Journal:  Prostate       Date:  2007-04-01       Impact factor: 4.104

2.  Basic science of hormonal therapy for prostate cancer.

Authors:  D M Peehl
Journal:  Rev Urol       Date:  2001

Review 3.  NF-κB signaling in prostate cancer: a promising therapeutic target?

Authors:  Garima Jain; Marcus V Cronauer; Mark Schrader; Peter Möller; Ralf B Marienfeld
Journal:  World J Urol       Date:  2011-11-16       Impact factor: 4.226

4.  The relationship between prostatic microvessel density and different concentrations of oestrogen/androgen in Sprague-Dawley rats.

Authors:  Bo Wang; Di Pan; Yong Ban; Zhaolin Sun; Ye Tian; Guangheng Luo
Journal:  Eur J Med Res       Date:  2022-06-07       Impact factor: 4.981

5.  Androgen receptor targets NFkappaB and TSP1 to suppress prostate tumor growth in vivo.

Authors:  Thomas Nelius; Stephanie Filleur; Alexander Yemelyanov; Irina Budunova; E Shroff; Yelena Mirochnik; Arin Aurora; Dorina Veliceasa; Wuhan Xiao; Zhou Wang; Olga V Volpert
Journal:  Int J Cancer       Date:  2007-09-01       Impact factor: 7.396

6.  Vascular density is highest in the proximal region of the mouse prostate.

Authors:  Gui-Min Wang; Bruce Kovalenko; E Lynette Wilson; David Moscatelli
Journal:  Prostate       Date:  2007-06-15       Impact factor: 4.104

Review 7.  Impact of preoperative 5α-reductase inhibitors on perioperative blood loss in patients with benign prostatic hyperplasia: a meta-analysis of randomized controlled trials.

Authors:  Yi-Ping Zhu; Bo Dai; Hai-Liang Zhang; Guo-hai Shi; Ding-Wei Ye
Journal:  BMC Urol       Date:  2015-06-02       Impact factor: 2.264

8.  Leuprorelin depot injection: patient considerations in the management of prostatic cancer.

Authors:  Zinelabidine Abouelfadel; E David Crawford
Journal:  Ther Clin Risk Manag       Date:  2008-04       Impact factor: 2.423

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.